Pre-order Enquiry
Request Free Sample
Global Breast Cancer Recurrence Score Test Market Research Report 2023
SKU ID : QYR-23550158 | Publishing Date : 18-Apr-2023
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Breast Cancer Recurrence Score Test Market Research Report 2023
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Recurrence Score Test Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Stage I Invasive Breast Cancer
1.2.3 Stage II Invasive Breast Cancer
1.2.4 Estrogen Receptor-positive Cancer
1.2.5 Lymph Node-negative Breast Cancer
1.3 Market by Application
1.3.1 Global Breast Cancer Recurrence Score Test Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Speciality Cancer Centers
1.3.4 Advanced Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Recurrence Score Test Market Perspective (2018-2029)
2.2 Breast Cancer Recurrence Score Test Growth Trends by Region
2.2.1 Global Breast Cancer Recurrence Score Test Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Breast Cancer Recurrence Score Test Historic Market Size by Region (2018-2023)
2.2.3 Breast Cancer Recurrence Score Test Forecasted Market Size by Region (2024-2029)
2.3 Breast Cancer Recurrence Score Test Market Dynamics
2.3.1 Breast Cancer Recurrence Score Test Industry Trends
2.3.2 Breast Cancer Recurrence Score Test Market Drivers
2.3.3 Breast Cancer Recurrence Score Test Market Challenges
2.3.4 Breast Cancer Recurrence Score Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Recurrence Score Test Players by Revenue
3.1.1 Global Top Breast Cancer Recurrence Score Test Players by Revenue (2018-2023)
3.1.2 Global Breast Cancer Recurrence Score Test Revenue Market Share by Players (2018-2023)
3.2 Global Breast Cancer Recurrence Score Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Recurrence Score Test Revenue
3.4 Global Breast Cancer Recurrence Score Test Market Concentration Ratio
3.4.1 Global Breast Cancer Recurrence Score Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Recurrence Score Test Revenue in 2022
3.5 Breast Cancer Recurrence Score Test Key Players Head office and Area Served
3.6 Key Players Breast Cancer Recurrence Score Test Product Solution and Service
3.7 Date of Enter into Breast Cancer Recurrence Score Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Recurrence Score Test Breakdown Data by Type
4.1 Global Breast Cancer Recurrence Score Test Historic Market Size by Type (2018-2023)
4.2 Global Breast Cancer Recurrence Score Test Forecasted Market Size by Type (2024-2029)
5 Breast Cancer Recurrence Score Test Breakdown Data by Application
5.1 Global Breast Cancer Recurrence Score Test Historic Market Size by Application (2018-2023)
5.2 Global Breast Cancer Recurrence Score Test Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Breast Cancer Recurrence Score Test Market Size (2018-2029)
6.2 North America Breast Cancer Recurrence Score Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Breast Cancer Recurrence Score Test Market Size by Country (2018-2023)
6.4 North America Breast Cancer Recurrence Score Test Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Breast Cancer Recurrence Score Test Market Size (2018-2029)
7.2 Europe Breast Cancer Recurrence Score Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Breast Cancer Recurrence Score Test Market Size by Country (2018-2023)
7.4 Europe Breast Cancer Recurrence Score Test Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Recurrence Score Test Market Size (2018-2029)
8.2 Asia-Pacific Breast Cancer Recurrence Score Test Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2018-2023)
8.4 Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Breast Cancer Recurrence Score Test Market Size (2018-2029)
9.2 Latin America Breast Cancer Recurrence Score Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Breast Cancer Recurrence Score Test Market Size by Country (2018-2023)
9.4 Latin America Breast Cancer Recurrence Score Test Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Recurrence Score Test Market Size (2018-2029)
10.2 Middle East & Africa Breast Cancer Recurrence Score Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2018-2023)
10.4 Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Breast Cancer Recurrence Score Test Introduction
11.1.4 Roche Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2018-2023)
11.1.5 Roche Diagnostics Recent Development
11.2 Braster
11.2.1 Braster Company Detail
11.2.2 Braster Business Overview
11.2.3 Braster Breast Cancer Recurrence Score Test Introduction
11.2.4 Braster Revenue in Breast Cancer Recurrence Score Test Business (2018-2023)
11.2.5 Braster Recent Development
11.3 Bremed
11.3.1 Bremed Company Detail
11.3.2 Bremed Business Overview
11.3.3 Bremed Breast Cancer Recurrence Score Test Introduction
11.3.4 Bremed Revenue in Breast Cancer Recurrence Score Test Business (2018-2023)
11.3.5 Bremed Recent Development
11.4 Forward Science Technologies
11.4.1 Forward Science Technologies Company Detail
11.4.2 Forward Science Technologies Business Overview
11.4.3 Forward Science Technologies Breast Cancer Recurrence Score Test Introduction
11.4.4 Forward Science Technologies Revenue in Breast Cancer Recurrence Score Test Business (2018-2023)
11.4.5 Forward Science Technologies Recent Development
11.5 Guided Therapeutics
11.5.1 Guided Therapeutics Company Detail
11.5.2 Guided Therapeutics Business Overview
11.5.3 Guided Therapeutics Breast Cancer Recurrence Score Test Introduction
11.5.4 Guided Therapeutics Revenue in Breast Cancer Recurrence Score Test Business (2018-2023)
11.5.5 Guided Therapeutics Recent Development
11.6 Varian Medical Systems
11.6.1 Varian Medical Systems Company Detail
11.6.2 Varian Medical Systems Business Overview
11.6.3 Varian Medical Systems Breast Cancer Recurrence Score Test Introduction
11.6.4 Varian Medical Systems Revenue in Breast Cancer Recurrence Score Test Business (2018-2023)
11.6.5 Varian Medical Systems Recent Development
11.7 LED Dental
11.7.1 LED Dental Company Detail
11.7.2 LED Dental Business Overview
11.7.3 LED Dental Breast Cancer Recurrence Score Test Introduction
11.7.4 LED Dental Revenue in Breast Cancer Recurrence Score Test Business (2018-2023)
11.7.5 LED Dental Recent Development
11.8 PWB Health
11.8.1 PWB Health Company Detail
11.8.2 PWB Health Business Overview
11.8.3 PWB Health Breast Cancer Recurrence Score Test Introduction
11.8.4 PWB Health Revenue in Breast Cancer Recurrence Score Test Business (2018-2023)
11.8.5 PWB Health Recent Development
11.9 Zilico Medical Diagnostics
11.9.1 Zilico Medical Diagnostics Company Detail
11.9.2 Zilico Medical Diagnostics Business Overview
11.9.3 Zilico Medical Diagnostics Breast Cancer Recurrence Score Test Introduction
11.9.4 Zilico Medical Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2018-2023)
11.9.5 Zilico Medical Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Breast Cancer Recurrence Score Test Market Research Report 2023
List of TablesTable 1. Global Breast Cancer Recurrence Score Test Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Stage I Invasive Breast Cancer
Table 3. Key Players of Stage II Invasive Breast Cancer
Table 4. Key Players of Estrogen Receptor-positive Cancer
Table 5. Key Players of Lymph Node-negative Breast Cancer
Table 6. Global Breast Cancer Recurrence Score Test Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Breast Cancer Recurrence Score Test Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Breast Cancer Recurrence Score Test Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Breast Cancer Recurrence Score Test Market Share by Region (2018-2023)
Table 10. Global Breast Cancer Recurrence Score Test Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Breast Cancer Recurrence Score Test Market Share by Region (2024-2029)
Table 12. Breast Cancer Recurrence Score Test Market Trends
Table 13. Breast Cancer Recurrence Score Test Market Drivers
Table 14. Breast Cancer Recurrence Score Test Market Challenges
Table 15. Breast Cancer Recurrence Score Test Market Restraints
Table 16. Global Breast Cancer Recurrence Score Test Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Breast Cancer Recurrence Score Test Market Share by Players (2018-2023)
Table 18. Global Top Breast Cancer Recurrence Score Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Recurrence Score Test as of 2022)
Table 19. Ranking of Global Top Breast Cancer Recurrence Score Test Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Breast Cancer Recurrence Score Test Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Breast Cancer Recurrence Score Test Product Solution and Service
Table 23. Date of Enter into Breast Cancer Recurrence Score Test Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Breast Cancer Recurrence Score Test Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Breast Cancer Recurrence Score Test Revenue Market Share by Type (2018-2023)
Table 27. Global Breast Cancer Recurrence Score Test Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Breast Cancer Recurrence Score Test Revenue Market Share by Type (2024-2029)
Table 29. Global Breast Cancer Recurrence Score Test Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Breast Cancer Recurrence Score Test Revenue Market Share by Application (2018-2023)
Table 31. Global Breast Cancer Recurrence Score Test Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Breast Cancer Recurrence Score Test Revenue Market Share by Application (2024-2029)
Table 33. North America Breast Cancer Recurrence Score Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Breast Cancer Recurrence Score Test Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Breast Cancer Recurrence Score Test Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Breast Cancer Recurrence Score Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Breast Cancer Recurrence Score Test Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Breast Cancer Recurrence Score Test Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Breast Cancer Recurrence Score Test Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Breast Cancer Recurrence Score Test Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Breast Cancer Recurrence Score Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Breast Cancer Recurrence Score Test Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Breast Cancer Recurrence Score Test Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Breast Cancer Recurrence Score Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Breast Cancer Recurrence Score Test Market Size by Country (2024-2029) & (US$ Million)
Table 48. Roche Diagnostics Company Detail
Table 49. Roche Diagnostics Business Overview
Table 50. Roche Diagnostics Breast Cancer Recurrence Score Test Product
Table 51. Roche Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million)
Table 52. Roche Diagnostics Recent Development
Table 53. Braster Company Detail
Table 54. Braster Business Overview
Table 55. Braster Breast Cancer Recurrence Score Test Product
Table 56. Braster Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million)
Table 57. Braster Recent Development
Table 58. Bremed Company Detail
Table 59. Bremed Business Overview
Table 60. Bremed Breast Cancer Recurrence Score Test Product
Table 61. Bremed Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million)
Table 62. Bremed Recent Development
Table 63. Forward Science Technologies Company Detail
Table 64. Forward Science Technologies Business Overview
Table 65. Forward Science Technologies Breast Cancer Recurrence Score Test Product
Table 66. Forward Science Technologies Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million)
Table 67. Forward Science Technologies Recent Development
Table 68. Guided Therapeutics Company Detail
Table 69. Guided Therapeutics Business Overview
Table 70. Guided Therapeutics Breast Cancer Recurrence Score Test Product
Table 71. Guided Therapeutics Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million)
Table 72. Guided Therapeutics Recent Development
Table 73. Varian Medical Systems Company Detail
Table 74. Varian Medical Systems Business Overview
Table 75. Varian Medical Systems Breast Cancer Recurrence Score Test Product
Table 76. Varian Medical Systems Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million)
Table 77. Varian Medical Systems Recent Development
Table 78. LED Dental Company Detail
Table 79. LED Dental Business Overview
Table 80. LED Dental Breast Cancer Recurrence Score Test Product
Table 81. LED Dental Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million)
Table 82. LED Dental Recent Development
Table 83. PWB Health Company Detail
Table 84. PWB Health Business Overview
Table 85. PWB Health Breast Cancer Recurrence Score Test Product
Table 86. PWB Health Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million)
Table 87. PWB Health Recent Development
Table 88. Zilico Medical Diagnostics Company Detail
Table 89. Zilico Medical Diagnostics Business Overview
Table 90. Zilico Medical Diagnostics Breast Cancer Recurrence Score Test Product
Table 91. Zilico Medical Diagnostics Revenue in Breast Cancer Recurrence Score Test Business (2018-2023) & (US$ Million)
Table 92. Zilico Medical Diagnostics Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Recurrence Score Test Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Breast Cancer Recurrence Score Test Market Share by Type: 2022 VS 2029
Figure 3. Stage I Invasive Breast Cancer Features
Figure 4. Stage II Invasive Breast Cancer Features
Figure 5. Estrogen Receptor-positive Cancer Features
Figure 6. Lymph Node-negative Breast Cancer Features
Figure 7. Global Breast Cancer Recurrence Score Test Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Breast Cancer Recurrence Score Test Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Speciality Cancer Centers Case Studies
Figure 11. Advanced Diagnostic Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Breast Cancer Recurrence Score Test Report Years Considered
Figure 14. Global Breast Cancer Recurrence Score Test Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Breast Cancer Recurrence Score Test Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Breast Cancer Recurrence Score Test Market Share by Region: 2022 VS 2029
Figure 17. Global Breast Cancer Recurrence Score Test Market Share by Players in 2022
Figure 18. Global Top Breast Cancer Recurrence Score Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Recurrence Score Test as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Breast Cancer Recurrence Score Test Revenue in 2022
Figure 20. North America Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Breast Cancer Recurrence Score Test Market Share by Country (2018-2029)
Figure 22. United States Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Breast Cancer Recurrence Score Test Market Share by Country (2018-2029)
Figure 26. Germany Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Breast Cancer Recurrence Score Test Market Share by Region (2018-2029)
Figure 34. China Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Breast Cancer Recurrence Score Test Market Share by Country (2018-2029)
Figure 42. Mexico Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Breast Cancer Recurrence Score Test Market Share by Country (2018-2029)
Figure 46. Turkey Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Breast Cancer Recurrence Score Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Roche Diagnostics Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023)
Figure 49. Braster Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023)
Figure 50. Bremed Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023)
Figure 51. Forward Science Technologies Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023)
Figure 52. Guided Therapeutics Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023)
Figure 53. Varian Medical Systems Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023)
Figure 54. LED Dental Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023)
Figure 55. PWB Health Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023)
Figure 56. Zilico Medical Diagnostics Revenue Growth Rate in Breast Cancer Recurrence Score Test Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Keyplayers in Global Breast Cancer Recurrence Score Test Market Research Report 2023
Roche DiagnosticsBraster
Bremed
Forward Science Technologies
Guided Therapeutics
Varian Medical Systems
LED Dental
PWB Health
Zilico Medical Diagnostics
